Grants and Contributions:
Title:
JOINTstat® - Germany and Australian Market Entry
Agreement Number:
928230
Agreement Value:
$27,000.00
Agreement Date:
May 9, 2019 - Feb 28, 2020
Description:
The 14-3-3 eta JOINTstat® test can be used as an aid in the diagnosis of patients with Rheumatoid Arthritis. Augurex plans to commercialize 14-3-3 eta tests and reagents in Germany & Australia to expand our commercial reach.
Organization:
National Research Council Canada
Expected Results:
CanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Unity, British Columbia, CA V5T 4T5
Reference Number:
172-2019-2020-Q1-928230
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
829919521
Recipient Type:
For-profit organization
Recipient's Legal Name:
Augurex Life Sciences Corp.
Federal Riding Name:
Vancouver East
Federal Riding Number:
59035
Program:
CanExport
Program Purpose:
CanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
541710